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Abstract
Globally, persons with diseases like leprosy, tuberculosis, H1N1, SARS 
or HIV/AIDS have been stigmatized. The ongoing Ebola virus disease 
(EVD) outbreak in West Africa has been the longest outbreak in the 
history of the disease and the first outbreak to ever occur in West 
Africa. The strain of Ebolavirus in West Africa is one of the most viru-
lent strains of the Filoviridae family and case fatalities can be as high 
as 90%. Treatment of EVD is mainly supportive and societal attributes 
contribute to stigmatization of the disease and ultimately the spread 
of the disease. The method used in this study was a search in major 
databases including PUBMED and Google Scholar. The search phrase 
used in PUBMED was Ebola stigma. In Google Scholar, the search 
phrases used included Ebola stigma, EVD, perception of disease, cul-
ture and disease. The study also included a review of current events 
and data from the World Health Organization (WHO) and Centers 
for Disease Control and Prevention (CDC). In this review, an overview 
of filoviral hemorrhagic fevers was discussed.  The cultural beliefs on 
the causes of diseases and the stigmatization of infectious diseases 
in history were examined. In addition, the virulence between severe 
acute respiratory syndrome (SARS) and EVD were compared. Speci-
fically, it examined Ebola stigmatization and identified societal attri-
butes responsible for the stigma and the implications for controlling 
the spread. It also points to ways to reduce EVD stigmatization as a 
way of controlling the spread of EVD.  While there is a lot of ongoing 
research for the cure and control of EVD, little attention is being 
paid to the role of stigmatization in the control of the disease. Fear 
is the driving force of EVD stigmatization because EVD is a virulent, 
fast killing disease that has no cure. Powerlessness is another driving 
force in stigmatization. The sensationalism in news reporting and the 
mistrust of the government are factors playing on fear and rumor. 
Counselling should be provided to the community before survivors of 
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Introduction
Ebola viruses are one of the causative pathogens 
of the filoviral hemorrhagic fevers [1]. The order 
Mononegavirales is the taxonomic home of Ebola 
viruses. Ebola viruses are from the Filoviridae family 
[2]. Filo viruses are enveloped, non-segmented, ne-
gative stranded RNA viruses [1]. In 1979, at a con-
gress on virology and class 4 agents in Johannes-
burg, South Africa, Filoviridae was proposed as a 
family name for Ebola viruses and Marburg viruses 
because of the long filamentous, circular, u-shaped 
morphological forms of the virions [3]. Filo means 
thread or filament in Latin [3]. Filo viruses exploit 
the host cells’ defenses to support their own re-
plication [4]. 
The Center for Disease Control and Prevention 
(CDC) introduced a classification system for biosafe-
ty on handling human pathogens [5]. Biosafety Level 
(BSL) 4 is the highest biosafety level and filoviruses 
are classified as pathogens requiring Biosafety Level 
4 containment [5]. The infectivity, the severity of 
disease, the transmissibility and the nature of the 
work being conducted are assessed before a clas-
sification is made [5]. Pathogens that require a Bio-
safety level- 4 containment are at risk of being po-
tentially transmitted by aerolization and can cause 
life-threatening disease for which there is no vaccine 
or therapy [6, 7]. 
Viral hemorrhagic fevers are caused by 23 envelo-
ped RNA viruses from four distinct taxonomic family 
of viruses [2]: Filoviridae, Arenaviridae, Bunyaviridae 
and flaviviridae [2]. Filoviridae, Bunyaviridae and Are-
naviridae are all negative stranded RNA viruses [2, 
8]. Flaviviridae are positive stranded RNA viruses [2, 
8]. It is not all the viruses in each family that cause 
viral hemorrhagic fevers and not all the viruses give 
hemorrhagic manifestations [2]. Viral hemorrhagic 
fever viruses have different means of transmission 
depending on the family [2]. Their specific transmis-
sion cycles are maintained by non- human primates, 
bats, rodents, humans, mosquitoes and ticks [2]. Fi-
gure 1 is a UNICEF poster highlighting the potential 
risk of meats from animals like bats, rodents and 
non-human primates.
EVD return home. Survivors of EVD should be counselled before going 
home. The government should set up a task force on stigmatization 
and make efforts to regain the trust of the people. Memorials for 
those that died from EVD should be erected in each of the districts 
affected. Schools should not be closed for long periods and should 
only be closed if there is recourse to distance education. Faith based 
organizations can also use the methods for distance education as a 
means to encourage their followers.
Keywords
Ebola virus disease; cultural beliefs; stigmatization; EVD survivors; outbreak; 
stigma; West Africa; societal attributes, filoviral hemorrhagic fever




Vol. 8 No. 14
doi: 10.3823/1613
© Under License of Creative Commons Attribution 3.0 License 3
Three virus genera belong to the family Filoviridae. 
These are Marburgvirus, (MARV) Ebolavirus (EBOV) 
and more recently, the Cuevavirus [2, 8-10]. Five 
species of Ebolaviruses have been isolated from the 
Ebola virus genus. These species are Sudan Ebolavi-
rus  (SEBOV/SUDV), Zaire Ebolavirus (ZEBOV/EBOV), 
Côte d’Ivoire Ebolavirus (CIEBOV/TAFV), Bundibugyo 
Ebolavirus  , (BEBOV/BDBV) and the Reston Ebolavi-
rus (REBOV/RESTV) [7, 8]. The first three have been 
responsible for large EVD outbreaks in sub- Saharan 
Africa [9]. The ongoing outbreak in West Africa is a 
local EBOV Zaire species variant, slightly genetically 
distinct from the Ebola virus species that caused 
the recent outbreak in the Democratic Republic of 
Congo and therefore supports the argument that it 
could not have been introduced from Central Afri-
ca [7, 9, 11, 12]. Marburgvirus and Cuevavirus each 
have a single species in their genera; MARV species 
and LLOV species [8, 12].
EVD in Africa
In 1976, southern Sudan experienced the first out-
break in what was later called Sudan Ebolavirus [13]. 
A total of 284 people were infected and 151 died 
[13]. In the same year, northern Zaire, now the De-
mocratic Republic of the Congo (DRC) had its first 
outbreak of a different species of Ebola virus that 
was later called the Zaire Ebolavirus [14]. There were 
318 infected persons and 280 died [14]. The Zaire 
Ebolavirus is responsible for the ongoing outbreak 
in the West African countries [10]. 
The recently discovered Cuevavirus was detected 
in dead, infected bats inside caves in Spain [8]. It 
was named Lloviu virus (LLOV) after the cave from 
which it was found [8]. Apart from the Reston Ebo-
lavirus that was discovered in monkeys imported 
from the Philipines, Cuevavirus is the only Ebola vi-
rus that was discovered outside Africa and was not 
isolated from human beings [8]. Figure 2 shows the 
distribution of the Ebola virus in Africa. 
Figure 1:  Poster on prevention of Ebola. Used with permission from UNICEF.
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Three of the species of Ebola viruses have varia-
ble case fatality ratios with the highest case fatality 
ratio being 60-90% for Zaire Ebolavirus species, 40-
60% for the Sudan Ebolavirus species and 25% for 
Bundibugyo Ebolavirus species [15]. There has only 
been one reported case of the Tai Forest Ebolavirus 
(Côte d’Ivoire Ebolavirus) and the virulence of the vi-
rus could not be determined [15,16]. Limited human 
studies have been done on the Ebola virus because 
of biosafety concerns, the remote location of the 
outbreaks in places with inadequate infrastructure, 
sporadic and unpredictable timing of the outbreaks 
and poor filovirus surveillance [7, 15]. 
Clinical Manifestations of EVD
The clinical manifestations from the virulence of 
the Ebola virus may be tempered down by pro-
per intensive care and stringent supportive care 
[15]. Since 1976, there have been 24 laboratory-
confirmed Ebola virus disease outbreaks [7, 17]. 
The incubation period of EVD is 2-21 days and a 
mean of 4-10 days [15]. A macropapular rash ap-
pears by the 5th-7th day of illness [7, 15]. Patients 
can develop thrombocytopenia and bleed interna-
lly and externally [12]. Externally, they can bleed 
from venipuncture sites. They can bleed from the 
gingiva, from the ears, the conjunctiva, the lungs, 
the vagina and the gastrointestinal tract [8, 9, 15, 
18]. The transmission of the virus is characterized 
by fever of sudden onset, weakness, chills, malaise, 
and myalgia [7]. 
The clinical manifestation of persons infected 
with EVD is non-specific because the clinical pre-
sentation is similar to other endemic diseases in the 
region [7, 15]. Diseases that are endemic in the re-
gion include Lassa fever, malaria and typhoid fever 
[7]. Patients that recover from the disease usually 
suffer from myelitis, recurrent hepatitis, psychosis or 
Figure 2:  Illustration of countries in Africa that have had an EVD outbreak (1967-2014). 
Map drawn by Titilola T. Obilade.
Other countries 
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uveitis [15]. In this current EVD outbreak, patients 
from Kenema, Sierra Leone that survived from EVD 
suffer from joint pain, muscle pain, visual problems, 
headaches and extreme fatigue [19]. On the websi-
te for WHO, these manifestations are described as 
Post Ebola Syndrome [19]. The disease affects all the 
systems. In a later stage of the disease, there could 
be shock, convulsions, severe electrolyte imbalance 
and disseminated intravascular coagulopathy. Death 
occurs from the disease 6-16 days after the onset 
of symptoms [2]. Patients that die from the disease, 
usually die from hypovolaemic shock and multiple 
organ failure [15]. In the current outbreak in Guinea, 
there have been more female deaths with a male 
to female ratio of 41: 59 and a median age of 35 
years [9]. The index case in the current outbreak 
was identified as a 2 year old child from Guécké-
dou, Guinea but the suspected, introductory animal 
source has not been identified [15].
Stigma
Stigma is a social construction that characteristically 
disenfranchises the stigmatized person or group of 
persons. Stigma was formerly defined as a physi-
cal deformity or a physical blemish until Goffman 
extended the definition of stigma beyond physical 
attributes [20, 21]. Goffman’s seminal article on stig-
ma classified it into three, broad groups: The first 
group belonged to those being stigmatized becau-
se of their physical deformities like those due to 
leprosy. The second group belonged to those stig-
matized because of perceived or real flaws in their 
character like ex-convicts, mental disorders and the 
unemployed. The third group was for those stigma-
tized according to their tribal affiliations to religion, 
nationality, sex and race [20]. 
Some researchers have contended that Goffman’s 
classification is archaic and insufficient to address 
stigma from health problems in low income coun-
tries and stigmas from cross cultural situations [21]. 
In addition, they contended that Goffman’s clas-
sifications were broad and ambiguous. A fourth 
classification that I would add to Goffman’s clas-
sification is rapid killer disease stigma (RKDS). The 
Ebolavirus was named after the Ebola River becau-
se previously, towns that were named after infec-
tious diseases became stigmatized like Lassa fever 
named after Lassa, Nigeria. In his narrative on the 
Ebolavirus outbreak in Yambuku, Zaire (now DRC), 
Peter Piot explained how the Ebolavirus got named 
after a river and not after a town because Karl Jo-
hnson and the rest of the epidemiologic team did 
not want the town to be stigmatized. A narrative 
from Piot’s book [22]:
Pierre argued for Yambuku virus, which had the 
advantage of simplicity; it was what most of us 
were already calling the disease. But Joel remin-
ded us that naming killer viruses after specific 
places can be very stigmatizing; with Lassa virus, 
discovered in 1969 in a small Nigerian town of 
that name, it had caused no end of problems to 
the people from that locality. Karl Johnson liked 
to call his viruses after rivers: he felt that took 
some of the sting out of geographical finger-
pointing. It was what he had done when he’d 
discovered Machupo virus in Bolivia in 1959, and 
it was clear that night that he had every inten-
tion of doing the same in Zaire. But we couldn’t 
call our virus after the majestic Congo River: a 
Congo-Crim virus already existed. Were there 
any other viruses near Yambuku? We charged 
en masse to a not-very large map of Zaire that 
was pinned up in the Fométro corridor. At that 
scale, it looked as though the closest river to 
Yambuku was called Ebola-“Black River,” in Lin-
gala. It seemed suitably ominous. (Piot, No time 
to lose: A life in pursuit of deadly viruses: WW 
Norton & Company; London 2012, pp; 56-57)
Cultural Beliefs on Causes of Diseases
A leprosy survey conducted in Aceh, Indonesia 
showed that they believed leprosy could be cau-
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sed by the curse of an angry father, wrath of God 
for committed sins, breaking of food and other 
taboos, body fluids and heredity [23]. In Plateau, 
Nigeria, leprosy was believed to be caused by in-
fection, witchcraft, breaking of taboos and heredity 
[23]. In Nepal, leprosy was believed to be caused 
by witchcraft and anger from one of the gods [23]. 
The people of Guinhangdan in the Philippines be-
lieved that illness was caused by sorcerers, witches 
or spirits. They also believed that until the illness 
was severe enough to hinder regular activities, they 
were not ill [24]. The Limbas of Sierra Leone from 
the Biriwa/Safroko in the south and the Tonko/
Sela from the west believe that leprosy is caused 
by witchcraft while the Limbas from the north, 
the Wara Wara believe that people infected with 
leprosy were witches [25]. Therefore, if a person 
from the Wara Wara region had leprosy, s/he was 
blamed but when a person from the south or west 
region had leprosy, they were pitied because they 
were considered victims. Leprosy patients from the 
Wara Wara region are respected as witches and 
houses are built for them. They also believed that 
leprosy was not transferred because only witches 
could have leprosy. The Tonko/Sela from the west 
and the Biriwa/Safroko from the south expel their 
leprosy patients [25]. 
In the United Kingdom, 45 study participants 
were stigmatized because people thought their 
lung cancer was caused by smoking even though 
lung cancer can be caused by other factors [26]. 
In another study conducted in the United King-
dom, researchers interviewed 1,620 women. The 
women were asked to rate how much they would 
blame patients with breast cancer, cervical cancer, 
bowel cancer, lung cancer, leukemia and chlamydia. 
The participants attributed the most blame to lung 
cancer and chlamydia. Leukamia and breast can-
cers were attributed the least blame [27]. Diseases 
that were seen as having behavioral origins were 
blamed on the infected persons. When African 
Americans from northern California were surveyed 
using a close-ended questionnaire on their beliefs 
on cancer, 65% of the respondents believed that 
cancer was a death sentence and more than 75% 
believed that during surgery, cancer could spread 
through the air [28]. 
In western Nigeria, onchocerciasis (nàrun) is belie-
ved to be caused by worms residing in the body. It is 
believed that worms normally reside in the body to 
induce fertility but that excess of the worms could 
cause onchocerciasis (nàrun). It is also believed that 
the hitching associated with onchocerciasis (nàrun) 
was caused by eating certain types of vegetables, 
cheese and that it could be caused by not bathing 
frequently. The local name for onchocerciasis in 
western Nigeria is nàrun. Nàrun is from the phrase 
iná òòrun`  (fire from heaven). They also belief that 
nàrun can spread from the water that comes out 
of the onchocercial skin lesion [29].
A study conducted in Zambia to identify cau-
ses of stigma related to tuberculosis and other 
opportunistic infections from HIV showed that 
judgment, blame and shame, fears of tuberculo-
sis transmission and government health policy and 
practice on tuberculosis were identified as causes 
of tuberculosis stigma [30]. The study showed that 
patients that were not infected with HIV but had 
tuberculosis did not feel stigmatized as much as 
those that were infected with tuberculosis and had 
HIV [30]. In the government clinics, patients that 
had tuberculosis had a separate waiting area which 
made it easy to identify patients that had tuber-
culosis. The people also believed that tuberculosis 
that was not associated with HIV/AIDS was caused 
by smoking tobacco or marijuana, drinking home 
brewed liquor, working in the mines or by abor-
tion. They also believed that tuberculosis could be 
caused by a person’s stubbornness. Further, they 
believed that stepping on the sputum or faeces of 
an infected person could cause the disease. Pas-
sing a place where an infected tuberculosis patient 
had urinated was also believed to cause tubercu-
losis [30].
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In a separate study conducted in South Africa, the 
participants believed that tuberculosis was caused 
by breaking cultural taboos like not abstaining from 
sex after the death of a family member. Further, the 
participants believed that tuberculosis could be cau-
sed by environmental pollution, excessive alcohol 
consumption and having sex with a woman who 
has just had a spontaneous abortion. In addition, 
they believed that patients receiving treatment for 
tuberculosis should abstain from sex [31].
Stigmatized Infectious Diseases in History
Leprosy has been a source of stigmatization since 
human history [32]. Globally, patients infected with 
leprosy were isolated and mandatorily quarantined 
for the rest of their life. They were treated in lepro-
sariums. Barriers that added to the burden of stig-
ma were removed after an effective treatment was 
discovered. Leprosariums around the world began 
to close although some countries still keep leprosy 
infected patients in leprosariums [33, 34].
 In 1946, patients with leprosy were allowed to 
vote. In 1947, leprosy was officially called Hansen’s 
disease to reduce the stigma attached to being ca-
lled a leper [35]. In 1947, The Public Health Service 
removed leprosy from the list of quarantinable di-
seases that required a travel permit. The other disea-
ses on the list of qurantinable diseases are cholera, 
diphtheria, infectious tuberculosis, plague, yellow 
fever, small pox and viral hemorrhagic fevers. 
 Severe acute respiratory syndrome was added 
to the list of quarantinable diseases in 2003 [36]. 
All the quarantinable diseases are included in the 
list of communicable diseases of public health sig-
nificance. HIV infection was added to the list of 
diseases of public health significance in 1987 [37]. 
The Human Immuno Deficiency Virus infection was 
among the list of communicable diseases of public 
health significance until 2010. The other diseases on 
the list of diseases of public health significance are 
active tuberculosis, infectious syphilis, gonorrhea, 
infectious leprosy, chancroid, and lymphogranulo-
ma inguinale.
In 2009, during the H1N1 influenza outbreak, 
a country in East Asia quarantined visiting natio-
nals from a North American country even when 
the visiting nationals were not sick because of the 
perception that the visiting nationals had the H1N1 
influenza flu [38]. The index case for H1N1 was from 
that North American country [38]. The estimated 
number of deaths due to the 2009 H1N1 influenza 
flu in the USA was 12,469 [39]. 
The 2002-2003 SARS outbreak infected 8096 
persons between November 1 2002 and July 31 
2003 and 774 people died [40] In the current EVD 
outbreak, 19,497 persons were infected between 
December 2013 and December 24, 2014. As of De-
cember 24, 2014, 7,588 people had died [41]. Table 
1 shows that the case fatality ratio for SARS is 9·6 % 
and 38.9% for EVD. The World Health Organization 
Ebola Response Team estimates the case fatality of 
the EVD to be 70% [42]. 





Total Number of 
Cases Including 
Suspected Cases
Time Period of 
Total Cases
Number of Case 
Fatalities
Number of Case Fatalities/
Total Number of Cases in 
Percentages
SARS 10 [40] 8096 [40]
1 Nov 2002-31 
July 2003 [40] 
774 [40] 9.6




[40] and [41] are listed in the references at the end of the manuscript.
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Leprosy, HIV/AIDS, tuberculosis, H1N1 and SARS 
instill a lot of fear in people because of what society 
has attributed to these diseases and those that get 
infected with any of these diseases are stigmatized. 
The attributions to these diseases are not without 
merit. Leprosy can leave physical deformities when 
not treated early. Medical textbooks describe the 
faces of those infected with leprosy as lion-like fa-
ces or leonine faces because of the way the face 
looks after it has been destroyed by leprosy. Physical 
deformities from leprosy are a source of stigmatiza-
tion because they cannot be hidden and are easily 
identifiable [43]. H1N1 was a pandemic in 2009 but 
it is no longer a pandemic even though it is still 
infecting people today. It is now considered a sea-
sonal flu [44]. 
The SARS outbreak lasted for about eight months 
and during that time, the overall estimated case 
fatality for SARS was 14%. The case fatality could 
be less or higher depending on the age of the pa-
tient and other factors [40]. Approximately eight 
months after the index case in the current EVD out-
break, the overall case fatality rate was 52% [45]. 
The introduction of multidrug therapy has reduced 
the incidence of leprosy. Anti-tuberculosis therapy 
is effective in treating tuberculosis if the treatment 
regimen is adhered to. The seasonal influenza vac-
cine can be taken to prevent H1N1 influenza. An-
tiretroviral therapy has been successful in reducing 
the disease burden of HIV/AIDS. There is no vaccine 
for SARS but it was eventually controlled during 
the 2003 outbreak. People infected with Leprosy, 
tuberculosis, H1N1, HIV/AIDS and SARS used to be 
severely stigmatized but as soon as an effective ma-
nagement became established, the stigma associa-
ted with them decreased markedly.
However, with the Ebolavirus there are still many 
mystifying areas. When the symptoms first appear, 
they can be misdiagnosed as malaria, typhoid fe-
ver or any tropical disease that is endemic in the 
regions that have been hit by the EVD. Further, the 
presentation in each patient is variable. Some pa-
tients present with bleeding and some do not. The 
case fatality is high. There is no known cure and 
the disease outcome is uncertain despite palliative 
treatment. The source of the animal infection and 
route of infection of the index case in the current 
EVD outbreak remain unknown, although several 
plausible causes have been suggested [9]. 
 The virulence of the disease is such that it can 
wipe out entire families [22] and has left many chil-
dren as orphans [22]. It has threatened the fabric 
of the culture of the affected nations and it has 
depleted their meagre resources [46-48].
 Public gatherings have been banned because of 
the risk of spreading the disease. Doctors, nurses 
and other health care workers have succumbed 
to the disease accentuating understaffed and over 
stretched manpower. The management of high con-
sequence pathogens includes early reporting, con-
tact tracing, isolation, quarantine, rumor and stigma 
management. Although the 2003 SARS spread to 
24 countries the death toll was less than in the pre-
sent EVD outbreak because of the implementation 
of early management protocols [49]. 
The index case of the present EVD outbreak was 
reported to have occurred in Guéckédou, Guinea 
in December 2013 [42] but it was not until March 
12, 2014 that Médecins Sans Frontières in Guinea 
was alerted [9]. The outbreak was initially graded 
as a level 2- emergency by the WHO Emergency 
Management Team but on 24 July, 2014 it was re- 
graded to 3 because of the severity of the outbreak 
and the incident of a Liberian traveler infected with 
EVD traveling to Nigeria [50, 51]. The declaration of 
Public Health Emergency almost nine months after 
the EVD index case occurred severely imparted the 
outcome in the present outbreak.
Culturally Perceived Causes of EVD 
The delay in reporting rapid killing diseases contri-
butes to the spread of the disease. In addition, a 
virulent disease that kills within a short period from 
the time of clinical manifestation and seems to de-
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cimate anyone in contact with an infected person 
fuels rumor, stigma and mistrust of the govern-
ment. Ebola virus disease stigmatization is under-
mining the control of the disease. In the prevention 
and control of EVD, the role of stigmatization must 
be considered.
When a disease defies explanation and rapidly 
sometimes takes away the life of the individual or 
disfigures the physical appearance, as in leprosy, 
people across different cultures tend to develop 
certain beliefs to explain the cause of the disease. 
In a medical anthropological study on EVD in res-
ponse to the 2003 Republic of Congo EVD outbreak 
[52], sorcery and the La Rose Croix Organization (an 
organization sponsored from abroad) were believed 
to be responsible for EVD outbreak. The Congole-
se believed that EVD was caused by a spirit or an 
object. They did not believe that EVD was caused 
by contact with sick individuals. They also believed 
that members of the La Rose Croix sent EVD to their 
victims. As the disease progressed and the people 
noticed that EVD infected anyone including those 
they perceived were the cause of the disease, the 
belief that it was caused by sorcery waned and they 
believed it was caused by the air or the wind. 
 There was also a political economic explanation 
to their beliefs. There was a history of colonialism 
and exploitation by Euro Americans before the out-
break. Some teachers were killed because the peo-
ple thought they were agents of the La Rose Croix 
organization. The people believed that the outbreak 
was caused by Euro-Americans to stop them from 
hunting. The Euro- Americans had invested in the 
Natural Parks and the local people believed that 
discouraging them from hunting was enhancing 
the investments of the Euro-Americans [52]. Fur-
ther, animals were a potential source of EVD and 
the people had been advised not to hunt certain 
animals. The poster in Figure 1 shows animals as 
a potential source of EVD. They also believed that 
the animals were poisoned by the Euro-Americans 
in an effort to control poaching on the animals [52]. 
A similar study conducted in northern Uganda on 
the perceived cause of EVD showed that the Acholi 
people had three models to explain the cause of 
EVD; the biomedical model and two indigenous 
models. The biomedical model followed the stan-
dard procedure for treating illnesses like malaria. 
The two indigenous models were beliefs that EVD 
was caused by Gemo or yat. Gemo was caused by 
a bad spirit and yat was caused by poison. They 
also believed that disrespect to the gods could bring 
Gemo. Although the belief was not scientific, the 
treatment of Gemo had similarities to the scientific 
management of isolating the EVD patient [53]. 
Traditionally, they bury the dead near their ho-
mes but if the disease was believed to be caused 
by Gemo, the burial took place further away from 
the home. They were afraid to go to the hospi-
tal because if they died at the hospital, their body 
would not be buried near their homes but would 
be buried in the airfield. The fear of going to the 
hospital was also heightened because they believed 
the Euro-Americans were placing the dead in body 
bags to sell their “body parts” [53].
Societal Attributes and Implications of 
Ebola Virus Disease Stigmatization
Ebola virus disease survivors are being stigmatized. 
Family members and health workers treating people 
with the EVD are stigmatized. During a previous 
outbreak in Uganda, the husband of a man who-
se wife died from EVD committed suicide becau-
se of the stigmatization [53]. Survivors of EVD lost 
their livelihood [53]. They were abandoned by their 
spouses. Their children were instructed not to touch 
them [53]. They were not welcome in the market. 
Survivors of EVD and family members of the EVD 
survivors were not allowed to use the same well as 
the rest of the community [53]. The women were 
more stigmatized than men and were rejected whe-
never they walked in the neighborhood [53, 54]. 
Health care workers working with EVD patients 
were also shunned by their family members. In a 
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study conducted in Gulu, Uganda, Kikwit, Demo-
cratic Republic of Congo and Republic of Congo, 
nurses working with patients infected with EVD and 
people living in communities with EVD were stigma-
tized and called Ebola people [54]. 
During an EVD outbreak in The Republic of Con-
go, four school teachers were murdered because 
the community was suspicious of their links to fo-
reign health workers helping to control the disease 
[52, 54]. In the current EVD outbreak, eight health 
workers on a health education campaign were 
attacked and killed by members of the community 
[55]. Rumors have been generated about the spread 
of EVD. These rumors eventually alienate the people 
from the government. The communities affected 
with EVD prefer to believe the rumor rather than 
the government. This element of mistrust prevents 
the people from reporting cases of EVD which in 
turn prevents contact tracing and the disease esca-
lates to exponential proportions.
Stigmatization has also magnified the spread of 
the disease because those infected are afraid of 
going to the hospital and be known as an Ebola 
patient. In addition, they are afraid of going to the 
hospital because if they die, their corpses would 
not be returned to their families [53]. Funeral rites 
are deeply rooted in these communities and their 
burial practice has been a major source of spread 
of EVD. As part of their burial practice, the dead 
body is washed and dressed by the paternal aunt 
or a female member from the paternal side [53]. 
Part of the burial ceremony allows male and female 
members to touch the body of the deceased [53]. 
They also wash their hands in a communal bowl 
[53].
While a lot research has been devoted to the cure 
for EVD, there is a paucity of recent research on 
the role of Ebola stigmatization in the control and 
prevention of EVD. The results from the evaluation 
of the role of Ebola stigmatization can be used to 
control the spread of the disease. On the 25th of 
October 2014 when the word Ebola was entered in 
PUBMED, it brought up 2149 search results. When 
the search phrase Ebola stigma was entered in PUB-
MED, it brought up only two published articles as 
shown in Figure 3. The articles were published in 
2012 and in 2002 [56, 57].
There is a need for more research on how to 
ameliorate stigmatization from rapid killing infec-
tious diseases because stigmatization will discoura-
ge those with the disease from reporting thereby 
escalating the disease. Further spread of the disease 
would increase fatalities, fear and rumors until it 
becomes a vicious cycle. Stigmatization leads to an 
increase in the morbidity on EVD survivors, their 
families and on their community members.
EVD Stigmatization
For the purpose of this paper, Ebola stigmatization 
means the social disenfranchisement of a person 
or a group of persons because of the stigmatizers’ 
perception, belief or fear that the stigmatized per-
son or persons can no longer belong to their com-
munity because of their associations with the EVD. 
A survivor of EVD, their community member, their 
family member, a health worker or an indigene from 
an EVD endemic country are considered to have 
associations with EVD. On the international level, in 
order to protect their countries from EVD, several 
countries have banned travel from the three most 
affected countries. In Africa, citizens from other 
African countries not affected by the EVD have stig-
matized citizens from the affected nations. In the 
2015 Africa Cup of Nations, even though Morocco 
was initially slated to host the game, it did not be-
cause of fears over EVD [58].
Table 1 shows the fatality of EVD to be about four 
times that of SARS. EVD and SARS are both caused 
by viruses. They both spread rapidly and can quickly 
cause death depending on several factors. Infections 
with both diseases require barrier nursing. They are 
both highly contagious. They are both sources of 
stigmatization. However, apart from the geographi-
cal locations of the infectious global threat of SARS 
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being different from the geographical locations of 
the EVD, the responses to SARS outbreak which 
succeeded in bringing SARS under control in eight 
months were different from the responses to the 
present EVD outbreak. South Africa was the only 
African country that had a case of SARS. It was 
a single, imported case and the patient died [59]. 
Since SARS was not prevalent in Africa, it would 
prove challenging to speculate on how SARS control 
might have fared if it had spread to more countries 
in the continent.
The case fatality ratio for EVD in the current out-
break is 70% [42]. Therefore, the people in EVD 
affected countries have a real and palpable fear 
of the EVD. There fears are substantiated by seve-
ral factors. There is no licensed cure for EVD. The 
disease has not spared any social class. It has not 
spared the revered traditional healers. Among the 
people in the affected nations, some of their cul-
tural beliefs give room to suspicion on the cause of 
the disease as could be seen when some teachers 
were murdered because of their suspected ties to 
La Rose Croix [52]. Traditional beliefs are very diffi-
cult to overcome. Further, in their lives, they have 
seen or known someone struck with the EVD. Even 
when they survive, they are left in a deficit state of 
health [60]. The WHO calls these myriad of deficits 
Post Ebola Syndrome [60]. In a case fatality of 70 
% if a household of 10 people all get EVD, and 
assuming they all go to hospital, only 3 persons 
are likely to return home alive. Their suspicions of 
the hospital and government are further heighte-
ned when the corpses are not returned to the fa-
mily. Therefore, there is a widening distrust and an 
increasing suspicion between the people and the 
hospital that they see as part of the government. 
This widening distrust is only waiting to erupt and 
it erupted in some cities when some health wor-
kers were attacked and killed by the community 
members [55]. 
Figure 3:  Screen shot of search results when Ebola stigma was entered in the search box on October 
25, 2014.
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The Human Development Indices in these affec-
ted countries are among the last 13 out of 187 
countries [61]. When a survivor returns from the 
hospital, they see a situation that they can control or 
at least a situation where they want to control be-
cause they have not been able to control everything 
else around their health. The EVD survivors often 
return home weak and sometimes with loss of vi-
sion in the eyes or other forms of morbidity [60]. 
The communities affected with EVD have not been 
able to control the associated deaths. They have not 
been able to control what happened to them in the 
hospital because those who die in the hospital are 
buried in unmarked graves contrary to their belie-
fs. In a published research in this present outbreak, 
informed consent was not taken from the patients 
before their clinical data was used in data analysis 
[9] because that research was in response to a public 
health concern to the EVD outbreak. However, the 
EVD patients and EVD caregivers may be suspicious 
about the data being collected. When a survivor 
returns, they try to regain some control over their 
already disturbed lives by preventing the EVD sur-
vivor or anyone associated with him/her from their 
community. 
The fear of being stigmatized with any association 
with EVD, the perception of risk, the sensationalism 
in news reporting from the media, the hysteria su-
rrounding EVD around the world, the number of 
those taken to the hospital and dying there being 
more than those who recover, the inability to per-
form burial rites, the perceived irreverence of their 
cultural rites, the fatalities witnessed, the morbidi-
ty that is sometimes associated with recovery from 
EVD, the helplessness of the people, chronic pover-
ty, inadequate sanitary practices, struggling health 
care systems, poor or nonexistent infrastructure, the 
cultural belief of the prevention and cause of the 
disease, the lack of trust between the people and 
the government and the helplessness of the gover-
nment are some of the societal attributes contribu-
ting to EVD stigmatization. 
The upward trajectory of cautionary measures by 
the CDC is also an added point of fear of EVD. Af-
ter one of the nurses that treated the index case of 
EVD in the USA got infected, the CDC revised their 
protocols ensuring that no parts of the body were 
exposed. Eventually, two of the nurses that treated 
the index case of EVD in the USA got infected and 
they both recovered. 
While it may be easy to cover up completely in 
personal protective equipment in a temperate re-
gion, it might not be so in tropical regions. The 
health care workers in West Africa are aware of 
the risks and their fears could be heightened by the 
development of EVD from nurses that looked after 
the index case in USA where there was access to 
better infrastructure to manage the EVD patient. 
Countries are giving financial support without 
sending the manpower to come to the affected 
countries because there are not enough clinicians 
willing to engage in basic care of EVD patients in 
remote locations that also have severe infrastructu-
ral challenges [62, 63]. The infrastructural challenges 
become more apparent when the two nurses that 
contracted EVD while in the USA fully recovered 
[64].
The Way Forward
The fears coming from different facets lead to mis-
trusting the government. The government needs to 
gradually earn back the trust of the people. The 
way forward has been divided into different levels.
Community level: Counselling should be provided 
to families that have had a patient with EVD. Before 
an EVD survivor is sent back home, s/he should be 
counselled. Similarly, the family should be counselled 
before the EVD survivor reenters the community. In 
Firestone district, Liberia, discharged EVD patients 
were reintegrated back into the community by award 
of a medical certificate of wellness, a celebration 
of the return of the EVD survivor and presentation 
of a solidarity package [65]. The solidarity package 
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consisted of a mattress, a mosquito net and other 
essential household items. At the reintegration ce-
remony, the EVD survivor was allowed to talk about 
his/her experience and the event was broadcast on 
radio and recorded for future educational purposes. 
In addition, members of the community participa-
ted in preparing for the reintegration ceremony [65]. 
Successful reintegration programs similar to those in 
Firestone district, Liberia could be replicated. The-
re should be individual ownership and community 
ownership in the control and prevention of EVD 
[66]. Sanitation should be improved at individual 
and community level.
Governmental Level: The Governments of the 
three most affected countries should set up a 
Task Force to manage EVD stigmatization. In an 
effort to reduce EVD stigmatization, the Task Force 
should broadcast meetings of EVD survivors inte-
racting with someone whose face is well known 
by the people. The prominent person could be 
the president, the vice president, a popular mu-
sician, a religious leader, a popular actress/actor 
or a popular athlete. While shaking of hands, fist 
bumping and elbow bumping should be discoura-
ged, the EVD survivor and the chosen prominent 
person should be seen interacting so as to dispel 
the fears that the EVD survivor is a harbinger of 
the disease. Non-touch techniques of greeting can 
be developed.
Health education and rumor dispelling should be 
included in the management of stigmatization. At-
tention should also be paid to people with special 
needs. People with special needs especially those 
that are completely blind may find it challenging 
to navigate through the demands necessitated by 
the EVD outbreak especially when they depend on 
touch for performing regular tasks and touching 
should be avoided. Those who use wheel chairs 
and walking sticks should be assisted in cleaning 
them every day.
Efforts should be made to increase the confiden-
ce of the people in the health care system. Protocols 
should be developed for basic medical care at the 
individual and community level. The government 
should plan ahead for future outbreaks and should 
collaborate with governments of other African na-
tions that have had several outbreaks of EVD. In 
addition, they should collaborate with Nigeria and 
Senegal, two African countries that successfully 
stopped the transmission of EVD in this current out-
break. The Democratic Republic of Congo just had 
a recent EVD outbreak unrelated to the outbreak in 
West Africa and on November 22, 2014, the WHO 
declared DRC free of EVD transmission. The past 
experiences that DRC has had in managing several 
EVD outbreaks played a role in the successful ter-
mination of the outbreak [67]. Basic amenities like 
potable water, refuse disposal and toilets should be 
provided to enable the people to practice effective, 
personal hygiene.
Individual and Community Ownership Level: Pre-
vention is a safer option than waiting for the disease 
to commence before treating. Therefore, individuals 
and communities should take ownership in the pre-
vention and control of the disease [66]. They should 
be responsible for doing everything within their pur-
view to prevent the disease. They should monitor 
their body temperatures twice daily at temperature 
stations provided by the government. They should 
practice safe personal hygiene on a daily basis. They 
should immediately self-isolate as soon as they no-
tice they have a raised temperature. Community 
ownership comes into play when the community 
members support the individual in self isolation by 
providing food and other necessities before health 
workers arrive. Prominent and respectable members 
of the community should be incorporated in health 
education to respectfully debunk myths around 
EVD. Village Health Workers are members of the 
community and can be trained on basic protocols 
on what to do if a member of the community gets 
infected.
Educational Level: Since schools have been clo-
sed, the government can make use of distance lear-
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Figure 4:  Poster on Ebola Virus Used with Permission from UNICEF.
ning by broadcasting educational programs through 
the radio, the television, mobile phone devices 
and the internet when the internet is accessible 
[68]. Nomadic children use distance learning tools 
to access education and the governments of the 
affected countries may consider distant learning re-
sources especially in densely populated areas [68]. 
However, schools are a great resource for health 
education in dire situations like in the current out-
break and should only be closed if there is access to 
distance education. Teachers are a good resource 
and can be trained to teach their pupils about per-
sonal hygiene and debunk the myths surrounding 
EVD. Similarly, since public gatherings are discou-
raged, faith based organizations may educate their 
followers against stigmatization through the radio, 
the television, the internet and mobile phone de-
vices. Posters like those in Figures 4 and 5 are a 
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Figure 5:  Poster on Ebola Virus Used with Permission from UNICEF.
good resource in educating the people about the 
do’s and don’ts in the spread of EVD.
Community-Government Collaboration Level: 
The Governments of the three most affected coun-
tries should consider building memorials in each 
of the districts affected. Cultural burial practices 
in the affected countries are deeply rooted and 
family members feel that they would no longer 
be able to connect to their dead, loved ones if 
they are buried in mass graves [69]. The memo-
rials should befit the many lives that have been 
lost to the EVD. These memorials would serve as 
a way for the people to get a closure on the loss 
of their loved ones. However, before building the-
se memorials, the Governments should allow the 
communities to be part of the planning, organizing 
and implementation so that they can get a sense 
of ownership and closure [66].
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United Nations: The United Nations should enga-
ge with states that are deficient in their contribu-
tions to the support efforts. While giving incentives 
to states that contribute might not be appropria-
te, The United Nations can develop methods that 
would make reluctant states to become more sup-
portive.
EVD Information Dissemination Level: The media 
has been disproportionally rife with reporting on 
the numbers of fatalities than on the survivors. We 
seem to hear only the somber number of fatalities 
by the WHO. While being honest about the disea-
se, there should be leverage in the communication 
about the number of fatalities and the number of 
survivors in order to diminish the fear perpetuated 
by the EVD. 
Conclusion
This paper has highlighted the societal role in the 
spread of EVD through stigmatization. The cultural 
explanations of different diseases were examined. 
Several factors that have contributed to EVD stig-
matization were identified. Some factors like im-
proved sanitation can be initiated at the individual 
level but some factors like creating a closure for the 
families of those that died from EVD would need 
assistance from the Governments of the affected 
countries. 
Provision of basic amenities like water, refuse 
disposal and toilets should be given a priority by 
the governments to enable the practice of proper 
personal hygiene. The Governments of the affec-
ted countries should implement efforts to win back 
the trust of the citizens. There should be leverage 
in news reporting on EVD. Health education and 
counselling of communities associated with EVD 
survivors should also be implemented. Distance 
education should only be considered as an option 
for schools if the resources for distance education 
are available. Although EVD is a preventable disea-
se and there is presently no licensed cure for the 
diseases, community efforts aimed at reducing the 
burden of EVD stigmatization would go a long way 
in the control and prevention of EVD.
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